ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

FEBT, For Pain Control, Shows Positive Results In Phase III

May 26, 2006

In Brief: ASCO Selects Four New Board Members; Mount Sinai’s Shank To Move To California

March 27, 1998

Bush Says National Dialogue On Cancer Needs To Correct Problems And Move On.

March 17, 2000

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001

Regulatory Agencies: HCFA Proposes Physician Transfer Of Drug Discounts To Medicare, Insurers

April 3, 1998